RE: A little perspective25 Jan 2022 18:37
HarChis,
The hope of good news was built into the expectation of results inline or better and a forward statement that lit the blue touch paper - in a good way.
Unfortunately, results were inline at best and a reiteration of 50% less revenue next year. As for the forward statement , well it seemed clear to me it's more or less as we are. On one hand covid is still at the forefront of the revenue generation and we will not move into big and exciting markets like Oncology or transplantation but instead use our portfolio and react to new emerging diseases immediately.
DA also made clear we will get more colour on this in April with the full year results. Therefore and by deduction I don't see anything coming till them, as he stated. Till then it's 2 to 3 months of not alot and the SP is rooted in a downtrend.
This may not be what agreeable with some but better opportunities may come along before April to buy.
I would say the biggest positive is the cash at the bank so reasonably should it go below this - probably not unless the signs are we won't be making money but spending it in the future. The issue today was - NO FUTURE PLANS FOR REVENUE GENERATION.
The question serious investors will ask is, has the company built out to wide and will this be a drag on cash at the bank going forwards.